Glaxosmithkline Plc (GSK)

 NULL
   
  • Closing Price Chg:
    $1.30
  • 52 Week High: NULL
  • 52 Week Low: $32.08
  • Currency: US Dollars
  • Shares Issued: 465.72m
  • Volume: 0
  • RiskGrade: 119
  • Beta: 0.25

Latest ShareCast News

Trump set to declare national emergency in US, freeing up funding

By Alexander Bueso

Date: Friday 13 Mar 2020

(Sharecast News) - The US is expected to declare a national emergency at the end of the week and call for a coordinated international response to contain the coronavirus and its economic fallout.

GSK ShareCast News

No recent information was found.

GSK Newspaper Links

GSK profits lifted by strong cancer drug sales 30-Jul-2025 Times
GlaxoSmithKline scraps sale of old drugs 05-Dec-2014 Telegraph
Glaxo sharpens axe to save £1bn as insurers and ... 01-Dec-2014 The Independent
GSK to cut hundreds of US jobs 01-Dec-2014 Telegraph
Ebola vaccine trials 'encouraging', says GSK 27-Nov-2014 Telegraph

GSK Tips & Analysis

Questor :GlaxoSmithKline 16-Apr-2014 Telegraph
Questor:GlaxoSmithKline 06-Oct-2011 Telegraph
Questor:GlaxoSmithKline 11-Aug-2011 Telegraph
Questor tip: GlaxoSmithKline 28-Jul-2011 Telegraph
Investment Column: GlaxoSmithKline 27-Jul-2011 The Independent

GSK News Wires

FDA Approves Promacta(R) (Eltrombopag), the Firs... 20-Nov-2008 PR Newswire
Study Found That Long Term Use of Advair Diskus(... 29-Oct-2008 PR Newswire
GlaxoSmithKline to Acquire Genelabs Technologies... 29-Oct-2008 PR Newswire
A New Interactive Consumer Experience Highlighti... 28-Sep-2007 PR Newswire
AUDIO from Medialink and GlaxoSmithKline: A New ... 28-Sep-2007 PR Newswire

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency US Dollars
Share Price NULL
Closing Price Change $ 1.30
% Change 0.00 %
52 Week High NULL
52 Week Low $32.08
Volume 0
Shares Issued 465.72m
Beta 0.25
RiskGrade 119

Trades for --2025

Time Volume / Share Price
0 @ $0.00

GSK Key Personnel

CEO Emma Walmsley

Top of Page